← Eichor
Condition: Abo Hemolytic Disease Of Newborn Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Abo Hemolytic Disease Of Newborn

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect H
NA · 1 location(s) · Tishreen University Hospital · NCT07110987Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN
Phase N/A · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT05842109Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling
Phase 2 · 1 location(s) · University of Calgary · NCT03214354
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.